Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Increases By 634.6%

GlucoTrack, Inc. (NASDAQ:GCTK) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 234,255 shares, a growth of 634.6% from the January 15th total of 31,889 shares. Based on an average daily volume of 1,698,025 shares, the short-interest ratio is presently 0.1 days. Currently, 23.3% of the company’s shares are sold short. Currently, 23.3% of the company’s shares are sold short. Based on an average daily volume of 1,698,025 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of GlucoTrack in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in GlucoTrack stock. Bank of America Corp DE increased its position in shares of GlucoTrack, Inc. (NASDAQ:GCTK) by 102,125.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,089 shares of the company’s stock after buying an additional 4,085 shares during the period. Bank of America Corp DE owned 0.85% of GlucoTrack worth $25,000 at the end of the most recent reporting period. 10.92% of the stock is currently owned by institutional investors and hedge funds.

GlucoTrack Price Performance

NASDAQ:GCTK traded up $0.01 during midday trading on Wednesday, hitting $1.80. 34,185 shares of the stock were exchanged, compared to its average volume of 686,344. GlucoTrack has a one year low of $1.52 and a one year high of $40.78. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $3.93 and a two-hundred day moving average price of $5.32. The company has a market capitalization of $1.81 million, a price-to-earnings ratio of -0.05 and a beta of 0.32.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.